/PRNewswire/ Endotronix, Inc., a privately-held digital health and medical technology company dedicated to advancing the treatment of heart failure (HF),.
Study met all primary safety and efficacy endpoints for the Cordella PA Pressure Sensor System for the treatment of NYHA class III heart failure patients LISLE, Ill., May 23, 2022